SEC Form 4 · accession 0001654954-18-003745
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth Masson
Officer — EVP, Head of Clinical Ops.
Period of report
Mar 19, 2018
Accepted (ET)
Apr 9, 2018 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F1 | $0.29 | Mar 19, 2018 | A | 310,000 | A | — | Mar 19, 2028 | Common Stock | 310,000 | 310,000 | D |
Explanation of responses
- F1The options vest as follows: 186,000 will vest over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining 124,000 options vest on the achievement of certain milestones, subject to continued employment.